U.S. General Merchandise and Department Stores Stock News

NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Is It Too Late To Consider Ouster (OUST) After Its 183% One Year Surge?

If you are wondering whether Ouster's share price still offers value after a strong run, it helps to start by lining up the recent returns with what the current valuation really implies. Ouster's stock closed at US$24.51, with returns of 26.8% over 30 days, 4.9% year to date and 183.4% over 1 year, while the last 7 days show a 9.1% decline and the 5 year figure sits at a 70.9% loss. Taken together, these figures suggest investors have been reassessing both potential and risk over different...
NasdaqGS:WMG
NasdaqGS:WMGEntertainment

Warner Music Group Extends Film Reach With Paramount As Valuation Gap Persists

Warner Music Group and Paramount Pictures have agreed a multi year, first look partnership to develop theatrical films based on Warner Music artists and songwriters. The deal focuses on creating new cinema projects that tap into both legendary and contemporary acts from Warner Music Group. This collaboration pairs a major recorded music company with a leading Hollywood studio to build film concepts around music IP. For investors watching NasdaqGS:WMG, this new film partnership sits...
NYSE:DFIN
NYSE:DFINCapital Markets

Is Donnelley Financial Solutions (DFIN) Pricing Look Attractive After Recent Share Price Weakness

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Is It Too Late To Consider Sigma Lithium (SGML) After Its Strong 1 Year Rally?

Wondering if Sigma Lithium's current share price reflects its true worth, or if the recent excitement has run ahead of the fundamentals? The stock last closed at US$23.65, with returns of 7.2% over 7 days, 61.7% over 30 days, 66.4% year to date, 218.7% over 1 year and 401.5% over 5 years, while the 3 year return stands at a loss of 40.0%. Recent coverage has focused on Sigma Lithium as a lithium producer, with investors watching how sentiment around the sector and the company's development...
NYSE:Q
NYSE:QSemiconductor

Is It Too Late To Consider Qnity Electronics (Q) After A 69% Year To Date Surge?

If you are wondering whether Qnity Electronics at around US$143.59 is richly priced or still offers value, this breakdown outlines what the current share price might be implying. The stock has returned 2.1% over the last 7 days, 20.7% over the past month, and 69.0% year to date, which has put valuation squarely on investors' radar. Recent coverage has focused on Qnity Electronics' position within the semiconductor sector and how investors are reassessing companies tied to data infrastructure...
NYSE:YSS
NYSE:YSSAerospace & Defense

Is York Space Systems (YSS) Offering Value After Recent 30 Day Share Price Jump

If you are wondering whether York Space Systems is fairly priced or offering an opportunity at current levels, the next sections break down what the numbers suggest about value. The stock recently closed at US$33.38, with returns of 0.7% over the past week, 21.1% over the last 30 days, and a small year to date decline of 0.7%. This may catch the eye of investors watching for a turning point in sentiment. Recent attention around York Space Systems has focused on its position in the space and...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion’s AI Drug Programs Show Early Clinical Progress And Valuation Gap

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical milestones across several AI-driven drug programs. REC-1245 showed encouraging early safety data in humans. Patient dosing has started for REC-4539, moving another asset into active clinical testing. REC-4881 produced meaningful efficacy signals in familial adenomatous polyposis, prompting engagement with the FDA about a potential registrational path. For investors watching NasdaqGS:RXRX, these program updates focus...
NYSE:PRI
NYSE:PRIInsurance

Primerica (PRI) Combined Ratio Of 65.2% Tests Bullish Profitability Narratives

Primerica (PRI) opened 2026 with Q1 revenue of US$885.9 million and basic EPS of US$6.00, supported by net income of US$190.1 million and a combined ratio of 65.2%, setting a clear tone for how the year is starting. The company has seen quarterly revenue move from US$803.4 million in Q4 2024 to US$819.5 million in Q1 2025 and then to US$885.9 million in Q1 2026. Over that period, basic EPS ranged from US$4.99 to US$6.36, pointing to a business that is still generating meaningful profits as...
NYSE:MWA
NYSE:MWAMachinery

Mueller Water Products Shifts Capital Toward Acquisitions To Expand Footprint

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...
NYSE:UDR
NYSE:UDRResidential REITs

UDR Shifts To Monthly Dividends And Expands Buybacks For Investors

UDR (NYSE:UDR) has shifted to monthly dividend payments, becoming the first major apartment REIT to use this payout schedule. The company paired the change in dividend frequency with an expansion of its share repurchase program. These moves followed Q1 results that were described as better than expected. UDR focuses on owning and operating multifamily apartment communities, a segment that often attracts income focused investors looking for regular cash flow from real estate. The switch to...
NYSE:DKL
NYSE:DKLOil and Gas

Delek Logistics Refinancing Shift Resets Debt Costs And Maturity Profile

Delek Logistics Partners (NYSE:DKL) has launched US$800 million in new senior notes due 2034. The partnership has also started a cash tender offer for its existing 2028 senior notes. The refinancing is intended to adjust its debt profile by using proceeds from the 2034 notes to address higher coupon 2028 and 2029 notes. For you as an investor, this refinancing move goes straight to the core of how Delek Logistics Partners, a midstream operator, finances its business. Adjusting maturities...
NasdaqGS:KLIC
NasdaqGS:KLICSemiconductor

Kulicke And Soffa (KLIC) Q2 EPS Rebound Tests Bearish Earnings Volatility Narrative

Kulicke and Soffa Industries (KLIC) has just turned in a punchy Q2 2026 scorecard, with revenue of US$242.6 million and basic EPS of US$0.67, alongside trailing 12 month EPS of US$1.05 on revenue of US$768.2 million. Over the past few quarters the company has seen revenue move from US$161.9 million in Q2 2025 to US$148.4 million in Q3 2025, US$177.6 million in Q4 2025, US$199.6 million in Q1 2026 and now US$242.6 million in Q2 2026. Quarterly EPS ranged from a loss of US$1.59 in Q2 2025 to...
NYSE:TPH
NYSE:TPHConsumer Durables

A Look At Tri Pointe Homes (TPH) Valuation After Strong Recent Returns And Full Pricing To Analyst Targets

What Tri Pointe Homes’ Recent Returns Tell You Tri Pointe Homes (TPH) has drawn attention after a past 3 months total return of 32.4% and year to date return of 48.7%. These figures are prompting investors to reassess the stock’s recent momentum and underlying fundamentals. See our latest analysis for Tri Pointe Homes. Tri Pointe Homes’ recent share price return over 90 days of 32.4% and year to date share price return of 48.7%, alongside a 5 year total shareholder return of 93.37%, points to...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

Discover May 2026's Top Stocks Estimated Below Intrinsic Value

Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings projected to grow at an annual rate of 16%. In such a thriving market environment, identifying stocks that are estimated to be trading below their intrinsic value can present unique opportunities for investors seeking potential growth and value.
NYSE:TIC
NYSE:TICProfessional Services

High Insider Ownership Boosts These Growth Stocks In May 2026

The United States market has experienced a robust performance, climbing 3.2% in the last week and rising by 31% over the past year, with earnings projected to grow by 16% annually in the coming years. In this thriving environment, growth companies with high insider ownership are particularly noteworthy as they often signal strong confidence from those closest to the business, aligning their interests with shareholders and potentially enhancing long-term value creation.
NYSE:MCB
NYSE:MCBBanks

Uncovering US Market's Hidden Gems with 3 Promising Stocks

Over the last 7 days, the United States market has risen by 3.2%, and in the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying promising stocks that combine solid fundamentals with growth potential can be key to uncovering hidden gems in the market.
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

Lattice Semiconductor’s AMI Deal Reshapes AI And Cloud Growth Story

Lattice Semiconductor (NasdaqGS:LSCC) agreed to acquire AMI for US$1.65b. The deal is structured as a transformative move into AI, server management, and cloud infrastructure. The transaction is expected to be immediately accretive to gross margins, free cash flow, and non GAAP earnings, subject to regulatory approval. Lattice Semiconductor focuses on low power programmable logic devices that sit inside a wide range of electronics, from industrial systems to data center hardware. By adding...
NasdaqGS:ANGI
NasdaqGS:ANGIInteractive Media and Services

Assessing Angi (ANGI) Valuation After Earnings Reveal Sales Decline And Shift To Quarterly Net Loss

Angi earnings shift draws investor focus Angi (ANGI) is in the spotlight after reporting first quarter 2026 results that showed sales of US$238.15 million, lower than the prior year, and a move from net income to a net loss. See our latest analysis for Angi. The earnings release and move to a quarterly net loss have coincided with a sharp reset in sentiment. Angi’s share price is at US$5.24 after a 90 day share price return of negative 55.78% and a 1 year total shareholder return of negative...
NYSE:UI
NYSE:UICommunications

Is It Too Late To Consider Ubiquiti (UI) After Its Sharp Multi‑Year Rally?

If you are wondering whether Ubiquiti at around US$926.69 is priced for perfection or still offers value, this article walks through what the current market price might be indicating. The stock has been volatile recently, with an 8.4% decline over the past week, a 10.7% return over 30 days, 63.6% year to date, 163.8% over 1 year, 435.7% over 3 years and 261.7% over 5 years. Recent attention on Ubiquiti has focused on its long term share price performance and what this means for current...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Is It Time To Reconsider Alnylam Pharmaceuticals (ALNY) After Recent RNAi Progress And Volatile Price Moves

Wondering whether Alnylam Pharmaceuticals at around US$295.91 is offering fair value right now, or if the price is running ahead of the story? This article breaks down what the numbers suggest. The stock has seen mixed returns with a 4.4% decline over the last 7 days and a 7.4% decline over 30 days, but it is still up 14.5% over 1 year, 43.6% over 3 years and 122.6% over 5 years. Recent headlines have focused on Alnylam Pharmaceuticals' role in RNA interference based therapies and how its...